Pharmacogenomics in Drug Discovery

Pharmacogenomics is the study of genome's function in responding to drugs.It is mixture of the genomics and pharmacology. Pharmacogenomics analyzes  how an individual's genetic makeup influences his / her response to drugs. It deals with the effect of genetic variation acquired and inherited ondrug reaction in patients by attributing gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug intake, delivery, metabolism, and elimination) and pharmacodynamic. For certain cases the term pharmacogenomics is used interchangeably with pharmacogenetics.


  • Pharmacometrics
  • Target based Drug Discovery
  • Reserve Pharmacology
  • Pharmacokinetic aspects

Related Conference of Pharmacogenomics in Drug Discovery

September 27-28, 2021

15th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
October 18-19, 2021

20th International Conference on Structural Biology

Rome, Italy
November 20-21, 2021

26th World Congress on Industrial Biotechnology

Chicago, USA
November 24-25, 2021

3rd Annual summit on Cell Signaling and Cancer Therapy

Vancouver, Canada
December 07-08, 2021

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-10, 2021

2nd International Conference on Geriatrics and Ageing

Sydney, Australia
March 10-11, 2022

14th World Congress on Stem Cell Research

Paris, France
April 14-15, 2022

15th World Conference on Human Genomics and Genomic Medicine

Singapore City, Singapore
April 14-15, 2022

9th World Congress on Human Genetics and Genetic Diseases

Singapore City, Singapore
April 29-30, 2022

26th Global Congress on Biotechnology

Vienna, Austria

Pharmacogenomics in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in